Which companies are leading the pack in terms of market share of the sequencing sector? Michael Eisenstein reports.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rohde, H. et al. N. Engl. J. Med. 365, 718–724 (2011).
Loman, N.J. et al. Nat. Biotechnol. 30, 434–439 (2012).
Koren, S. et al. Nat. Biotechnol. 30, 693–700 (2012).
Peters, B.A. et al. Nature 487, 190–195 (2012).
Quail, M. et al. BMC Genomics 13, 341 (2012).
Lam, H.Y. et al. Nat. Biotechnol. 30, 78–82 (2011).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eisenstein, M. The battle for sequencing supremacy. Nat Biotechnol 30, 1023–1026 (2012). https://doi.org/10.1038/nbt.2412
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2412